Lifecore Biomedical Inc (LFCR)
5.63
-0.14
(-2.43%)
USD |
NASDAQ |
May 17, 13:38
Lifecore Biomedical Market Cap: 171.98M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 176.26M |
| May 15, 2024 | 182.98M |
| May 14, 2024 | 186.95M |
| May 13, 2024 | 186.64M |
| May 10, 2024 | 191.83M |
| May 09, 2024 | 200.69M |
| May 08, 2024 | 203.14M |
| May 07, 2024 | 209.86M |
| May 06, 2024 | 203.44M |
| May 03, 2024 | 195.19M |
| May 02, 2024 | 193.97M |
| May 01, 2024 | 196.72M |
| April 30, 2024 | 196.11M |
| April 29, 2024 | 197.33M |
| April 26, 2024 | 201.46M |
| April 25, 2024 | 202.83M |
| April 24, 2024 | 193.36M |
| April 23, 2024 | 197.03M |
| April 22, 2024 | 192.14M |
| April 19, 2024 | 204.36M |
| April 18, 2024 | 192.90M |
| April 17, 2024 | 199.47M |
| April 16, 2024 | 199.78M |
| April 15, 2024 | 190.92M |
| April 12, 2024 | 185.11M |
| Date | Value |
|---|---|
| April 11, 2024 | 188.47M |
| April 10, 2024 | 178.70M |
| April 09, 2024 | 187.86M |
| April 08, 2024 | 183.59M |
| April 05, 2024 | 187.56M |
| April 04, 2024 | 186.95M |
| April 03, 2024 | 187.86M |
| April 02, 2024 | 168.62M |
| April 01, 2024 | 176.87M |
| March 28, 2024 | 162.20M |
| March 27, 2024 | 157.93M |
| March 26, 2024 | 157.62M |
| March 25, 2024 | 164.95M |
| March 22, 2024 | 158.54M |
| March 21, 2024 | 153.96M |
| March 20, 2024 | 153.04M |
| March 19, 2024 | 219.63M |
| March 18, 2024 | 219.33M |
| March 15, 2024 | 225.44M |
| March 14, 2024 | 226.96M |
| March 13, 2024 | 227.25M |
| March 12, 2024 | 229.32M |
| March 11, 2024 | 223.41M |
| March 08, 2024 | 234.04M |
| March 07, 2024 | 232.27M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
50.63M
Minimum
Mar 17 2023
374.87M
Maximum
Jun 07 2021
276.30M
Average
291.00M
Median
Jul 11 2022
Market Cap Benchmarks
| Aquestive Therapeutics Inc | 288.59M |
| SELLAS Life Sciences Group Inc | 86.05M |
| ADMA Biologics Inc | 2.133B |
| Relmada Therapeutics Inc | 100.78M |
| Jaguar Health Inc | 75.14M |
Market Cap Related Metrics
| Price | 5.63 |